The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells

Anne Françoise Rénert, Pierre Leprince, Marc Dieu, Jenny Renaut, Martine Raes, Vincent Bours, Jean Paul Chapelle, Jacques Piette, Marie Paule Merville, Marianne Fillet

Research output: Contribution to journalArticlepeer-review

Abstract

Ceramides are central molecules in sphingolipid metabolism. They are involved in the regulation of cancer-cell growth, differentiation, senescence and apoptosis. To better understand how these secondary messengers induce their biological effects, adenocarcinoma cells (HCT116) were treated with exogenous long-chain ceramides (C16-ceramide) in order to mimic endogenous sphingolipids. This treatment induced a decrease of cell viability partly due to apoptosis as shown by PARP cleavage and a decrease of pro-caspase 3. Two-dimensional differential in-gel electrophoresis (2D-DIGE) revealed the differential expression of 51 proteins in response to C16-ceramide. These proteins are notably involved in cell proliferation, apoptosis, protein transport and transcriptional regulation. Among them, the cell death-promoting factor Btf was found to be implicated in the apoptotic signal triggered by ceramide. In adenocarcinoma cells, Btf regulates apoptosis related proteins such as Mdm2, p53, BAX and pBcl-2 and thus plays an important role in the ceramide mediated cell death. These findings bring new insight into the proapoptotic ceramide-dependent signaling pathway. © 2009 American Chemical Society.

Original languageEnglish
Pages (from-to)4810-4822
Number of pages13
JournalJournal of Proteome Research
Volume8
Issue number10
DOIs
Publication statusPublished - 2009

Keywords

  • 2D-DIGE
  • Apoptosis
  • Btf
  • Cancer cells
  • Ceramide

Fingerprint

Dive into the research topics of 'The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells'. Together they form a unique fingerprint.

Cite this